Laura Gault
Hoofd Techniek/Wetenschap/O&O bij SAGE THERAPEUTICS, INC.
Vermogen: 3 083 $ op 30-04-2024
Actieve functies van Laura Gault
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
| SAGE THERAPEUTICS, INC. | Hoofd Techniek/Wetenschap/O&O | 31-10-2022 | - |
Loopbaan van Laura Gault
Eerdere bekende functies van Laura Gault
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
| ALEXION PHARMACEUTICALS, INC. | Corporate Officer/Principal | 01-01-2019 | 01-11-2022 |
| VERTEX PHARMACEUTICALS INCORPORATED | Corporate Officer/Principal | 01-01-2017 | 01-03-2019 |
Opleiding van Laura Gault
| Case Western Reserve University | Doctorate Degree |
| University of Pittsburgh | Undergraduate Degree |
Statistieken
Internationaal
| Verenigde Staten | 6 |
Operationeel
| Corporate Officer/Principal | 2 |
| Chief Tech/Sci/R&D Officer | 1 |
| Doctorate Degree | 1 |
Sectoraal
| Health Technology | 4 |
| Consumer Services | 3 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
| Beursgenoteerde bedrijven | 2 |
|---|---|
| SAGE THERAPEUTICS, INC. | Health Technology |
| VERTEX PHARMACEUTICALS INCORPORATED | Health Technology |
| Bedrijven in privébezit | 1 |
|---|---|
Alexion Pharmaceuticals, Inc.
 Alexion Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Alexion Pharmaceuticals, Inc. engages in the business of serving patients and families affected by rare diseases and devastating conditions through the discovery, development, and commercialization of life-changing medicines. The firm also focuses on the development of haematology, nephrology, neurology, metabolic disorders, cardiology, and ophthalmology. The company was founded by Joseph A. Madri, David W. Keiser, Stephen P. Squinto, and Leonard Bell in January 1992 and is headquartered in Boston, MA. | Health Technology |
- Beurs
- Insiders
- Laura Gault
- Ervaring
